Filing Details
- Accession Number:
- 0001213900-25-070759
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-08-01 18:05:03
- Reporting Period:
- 2025-07-30
- Filing Date:
- 2025-08-01
- Accepted Time:
- 2025-08-01 18:05:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
2032966 | Acuren Corp | TIC | Services-Business Services, Nec (7389) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
2042765 | Talman Pizzey | C/O Acuren Corporation 14434 Medical Complex Drive, Suite 100 Tomball TX 77377 | Chief Executive Officer | Yes | Yes | No | No |
Transaction Summary
Number of Shares After Transactions: | 436,667 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-07-30 | 36,667 | $0.00 | 436,667 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Acquisiton | 2025-07-30 | 36,667 | $0.00 | 36,667 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
73,333 | No | 4 | M | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Performance Based Restricted Stock Units | $0.00 | 110,000 | 110,000 | Direct | ||
Common Stock | Restricted Stock Units | $0.00 | 73,333 | 73,333 | Direct | ||
Common Stock | Performance Based Restricted Stock Units | $0.00 | 146,667 | 146,667 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
110,000 | 110,000 | Direct | |
73,333 | 73,333 | Direct | |
146,667 | 146,667 | Direct |
Footnotes
- On July 30, 2025, 36,667 of the Reporting Person's restricted stock units were settled for an equal number of shares of the Issuer's Common Stock.
- Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
- These restricted stock units vest 33 1/3% on the first through third anniversaries of the grant date (July 30, 2024).
- Each performance based restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
- Subject to the volume weighted average price ("VWAP") of the Issuer's Common Stock reaching a specified price over a ten (10) consecutive trading day period at any time during the period commencing on February 18, 2025 and ending on July 30, 2029 (the "VWAP Achievement Period"), these performance based restricted stock units shall vest on the later of (x) July 30, 2025 and (y) the calendar day following the last day of the VWAP Achievement Period.
- These restricted stock units vest on the third anniversary of the grant date (April 11, 2025).
- These performance restricted stock units have a three-year performance period and to the extent earned will vest on April 11, 2028. The number of shares of Common Stock that will be earned is subject to decrease based on the results of the performance condition.